• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection

tetano

Editor, Senior Moderator
Cell Rep


. 2025 Apr 11;44(4):115557.
doi: 10.1016/j.celrep.2025.115557. Online ahead of print. Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection

Lela Kardava[SUP] 1 [/SUP], James Lim[SUP] 2 [/SUP], Clarisa M Buckner[SUP] 1 [/SUP], Felipe Lopes de Assis[SUP] 1 [/SUP], Xiaozhen Zhang[SUP] 1 [/SUP], Wei Wang[SUP] 1 [/SUP], Mattie L Melnyk[SUP] 1 [/SUP], Omar El Merhebi[SUP] 1 [/SUP], Krittin Trihemasava[SUP] 1 [/SUP], I-Ting Teng[SUP] 3 [/SUP], Robin Carroll[SUP] 3 [/SUP], Yogita Jethmalani[SUP] 3 [/SUP], Mike Castro[SUP] 3 [/SUP], Bob C Lin[SUP] 3 [/SUP], Lauren H Praiss[SUP] 1 [/SUP], Catherine A Seamon[SUP] 4 [/SUP], Peter D Kwong[SUP] 5 [/SUP], Richard A Koup[SUP] 3 [/SUP], Leonid Serebryannyy[SUP] 3 [/SUP], David C Nickle[SUP] 6 [/SUP], Tae-Wook Chun[SUP] 1 [/SUP], Susan Moir[SUP] 7 [/SUP]



Affiliations
Free article Abstract

Long-lived humoral memory is key to durable immunity against pathogens yet remains challenging to define due to heterogeneity among antigen-reactive B cells. We addressed this gap through longitudinal sampling over the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccinations with or without breakthrough infection. High-dimensional phenotypic profiling performed on ∼72 million B cells showed that receptor-binding domain (RBD) reactivity was associated with five distinct immunoglobulin G (IgG) B cell populations. Two expressed the activation marker CD71, both correlated with neutralizing antibodies, yet the one lacking the memory marker CD27 was induced by vaccination and blunted by infection. Two were resting memory populations; one lacking CD73 arose early and contributed to cross-reactivity; the other, expressing CD73, arose later and correlated with neutralizing antibodies. The fifth, a rare germinal center-like population, contributed to recall responses and was highly cross reactive. Overall, robust and distinct responses to booster vaccination overcame the superiority of hybrid immunity provided by breakthrough infection.

Keywords: B cells; COVID-19 mRNA vaccines; CP: Immunology; SARS-CoV-2; adaptive immune memory; antibodies; booster vaccination; breakthrough infection; hybrid immunity.

 
Back
Top Bottom